A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020)

Conditions: Bipolar I Disorder Interventions: Drug: MK-8189; Drug: Placebo Sponsors: Merck Sharp& Dohme LLC Not yet recruiting

Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials